Microphysiological modeling of the reproductive tract: A fertile endeavor

Experimental Biology and Medicine

Volumn 239, Issue 9, 2014, Pages 1192-1202

  Eddie, Sharon L ^a   Kim, J Julie ^b   Woodruff, Teresa K ^b   Burdette, Joanna E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Microphysiological modeling; repro on a chip; reproductive signaling

Indexed keywords

ANDROGEN BINDING PROTEIN; C REACTIVE PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CHORIONIC GONADOTROPIN; CYTOCHROME P450; CYTOCHROME P450 3A4; ESTROGEN; FOLLITROPIN; GROWTH FACTOR; GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LUTEINIZING HORMONE; MULTIDRUG RESISTANCE PROTEIN 1; OVIDUCTAL GLYCOPROTEIN 1; PROGESTERONE; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ACCESSORY SEX GLAND; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DRUG SCREENING; DRUG TOXICITY; ENDOCRINE FUNCTION; EPIDIDYMIS; FEMALE GENITAL SYSTEM; GENITAL SYSTEM; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; KUPFFER CELL; LIVER DISEASE; LIVER FUNCTION; MALE GENITAL SYSTEM; MICROENVIRONMENT; MICROTECHNOLOGY; MODEL; NONHUMAN; OVARY; PATHOPHYSIOLOGY; PENIS; PHYSIOLOGY; SEX DIFFERENCE; TESTIS; TOXICITY TESTING; URETHRA; UTERINE CERVIX; UTERINE TUBE; UTERUS; VAGINA; ANIMAL; BIOLOGICAL MODEL; EQUIPMENT; FEMALE; LAB ON A CHIP; MALE; METHODOLOGY; MICROPHYSIOLOGICAL MODELING; REPRO-ON-A-CHIP; REPRODUCTIVE SIGNALING; REVIEW; TISSUE CULTURE TECHNIQUE;

MICROPHYSIOLOGICAL MODELING; REPRO-ON-A-CHIP; REPRODUCTIVE SIGNALING;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FEMALE; GENITALIA, FEMALE; GENITALIA, MALE; HUMANS; LAB-ON-A-CHIP DEVICES; MALE; MODELS, BIOLOGICAL; TISSUE CULTURE TECHNIQUES;

EID: 84907015995     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214529387     Document Type: Article

References (116)

1. Huh D,Hamilton GA,Ingber DE.From 3D cell culture to organs-on-chips.Trends Cell Biol. 2011;21:745-54
2. Abbott A.Cell culture: biology's new dimension.Nature. 2003;424:870-2
3. Meer ADVD,Berg AVD.Organs-on-chips: breaking the in vitro impasse.Integr Biol. 2012;4:461-70
4. Olson H,Betton G,Robinson D,Thomas K,Monro A,Kolaja G,Lilly P,Sanders J,Sipes G,Bracken W,Dorato M,Van Deun K,Smith P,Berger B,Heller A.Concordance of the toxicity of pharmaceuticals in humans and in animals.Regul Toxicol Pharmacol. 2000;32:56-67
5. Saunders EJ,Saunders JA.Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin.Health Care Women Int. 1990;11:423-32
6. Grosberg A,Alford PW,McCain ML,Parker KK.Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip.Lab Chip. 2011;11:4165-73
7. Gunther A,Yasotharan S,Vagaon A,Lochovsky C,Pinto S,Yang J,Lau C,Voigtlaender-Bolz J,Bolz S-S.A microfluidic platform for probing small artery structure and function.Lab Chip. 2010;10:2341-9
8. Jang K-J,Suh K-Y.A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells.Lab Chip. 2010;10:36-42
9. Domansky K,Inman W,Serdy J,Dash A,Lim MHM,Griffith LG.Perfused multiwell plate for 3D liver tissue engineering.Lab Chip. 2010;10:51-8
10. Huh D,Matthews BD,Mammoto A,Montoya-Zavala M,Hsin HY,Ingber DE.Reconstituting organ-level lung functions on a chip.Science. 2010;328:1662-8
11. Zhang C,Zhao Z,Abdul Rahim NA,van Noort D,Yu H.Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments.Lab Chip. 2009;9:3185-92
12. Nicolson TJ,Mellor HR,Roberts RR.Gender differences in drug toxicity.Trends Pharmacol Sci. 2010;31:108-14
13. Spoletini I,Vitale C,Malorni W,Rosano GM.Sex differences in drug effects: interaction with sex hormones in adult life.Handb Exp Pharmacol. 2012;(214):91-105
14. Koren G,Nordeng H,MacLeod S.Gender differences in drug bioequivalence: time to rethink practices.Clin Pharmacol Ther. 2013;93:260-2
15. Soldin O,Mattison D.Sex differences in pharmacokinetics and pharmacodynamics.Clin Pharmacokinet. 2009;48:143-57
16. McGee EA,Hsueh AJ.Initial and cyclic recruitment of ovarian follicles.Endocr Rev. 2000;21:200-14
17. Drummond AE.The role of steroids in follicular growth.Reprod Biol Endocrinol. 2006;4:16-16
18. Goldman S,Shalev E.MMPS and TIMPS in ovarian physiology and pathophysiology.Front Biosci. 2004;9:2474-83
19. Maybin JA,Critchley HO.Steroid regulation of menstrual bleeding and endometrial repair.Rev Endocr Metab Disord. 2012;13:253-63
20. Kurman RJ,Shih Ie M.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm.Hum Pathol. 2011;42:918-31
21. Mahmood T,Saridogan E,Smutna S,Habib AM,Djahanbakhch O.The effect of ovarian steroids on epithelial ciliary beat frequency in the human fallopian tube.Hum Reprod. 1998;13:2991-4
22. Maia HS,Coutinho EM.Peristalsis and antiperistalsis of the human fallopian tube during the menstrual cycle.Biol Reprod. 1970;2:305-14
23. Verhage HG,Fazleabas AT,Mavrogianis PA,O'Day-Bowman MB,Donnelly KM,Arias EB,Jaffe RC.The baboon oviduct: characteristics of an oestradiol-dependent oviduct-specific glycoprotein.Hum Reprod Update. 1997;3:541-52
24. Wanggren K,Stavreus-Evers A,Olsson C,Andersson E,Gemzell-Danielsson K.Regulation of muscular contractions in the human fallopian tube through prostaglandins and progestagens.Hum Reprod. 2008;23:2359-68
25. Bulletti C,de Ziegler D,Polli V,Diotallevi L,Del Ferro E,Flamigni C.Uterine contractility during the menstrual cycle.Hum Reprod. 2000;15:81-9
26. Mulac-Jericevic B,Conneely OM.Reproductive tissue selective actions of progesterone receptors.Reproduction. 2004;128:139-46
27. Timmons B,Akins M,Mahendroo M.Cervical remodeling during pregnancy and parturition.Trends Endocrinol Metab. 2010;21:353-61
28. Gorodeski GI.Estrogen increases the permeability of the cultured human cervical epithelium by modulating cell deformability.Am J Physiol. 1998;275:C888-99
29. Gorodeski GI,Hopfer U,Liu CC,Margles E.Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells.Endocrinology. 2005;146:816-24
30. Cicinelli E,Einer-Jensen N,Galantino P,Alfonso R,Nicoletti R.The vascular cast of the human uterus: from anatomy to physiology.Ann N Y Acad Sci. 2004;1034:19-26
31. Edson MA,Nagaraja AK,Matzuk MM.The mammalian ovary from genesis to revelation.Endocr Rev. 2009;30:624-712
32. Sharpe RM.Local control of testicular function.Q J Exp Physiol. 1983;68:265-87
33. Griswold MD.Protein secretions of Sertoli cells.Int Rev Cytol. 1988;110:133-56
34. Boepple PA,Hayes FJ,Dwyer AA,Raivio T,Lee H,Crowley WF,Pitteloud N.Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function.J Clin Endocrinol Metab. 2008;93:1809-14
35. Hofer D,Drenckhahn D.Cytoskeletal differences between stereocilia of the human sperm passageway and microvilli/stereocilia in other locations.Anat Rec. 1996;245:57-64
36. Turner TT.On the epididymis and its role in the development of the fertile ejaculate.J Androl. 1995;16:292-8
37. Guyonnet B,Dacheux F,Dacheux JL,Gatti JL.The epididymal transcriptome and proteome provide some insights into new epididymal regulations.J Androl. 2011;32:651-64
38. Pelliniemi LJ,Dym M,Gunsalus GL,Musto NA,Bardin CW,Fawcett DW.Immunocytochemical localization of androgen-binding protein in the male rat reproductive tract.Endocrinology. 1981;108:925-31
39. Fan X,Robaire B.Orchidectomy induces a wave of apoptotic cell death in the epididymis.Endocrinology. 1998;139:2128-36
40. Takagi-Morishita Y,Kuhara A,Sugihara A,Yamada N,Yamamoto R,Iwasaki T,Tsujimura T,Tanji N,Terada N.Castration induces apoptosis in the mouse epididymis during postnatal development.Endocr J. 2002;49:75-84
41. O'Hara L,Welsh M,Saunders PT,Smith LB.Androgen receptor expression in the caput epididymal epithelium is essential for development of the initial segment and epididymal spermatozoa transit.Endocrinology. 2011;152:718-29
42. Jones RC.To store or mature spermatozoa? The primary role of the epididymis.Int J Androl. 1999;22:57-67
43. Koslov DS,Andersson KE.Physiological and pharmacological aspects of the vas deferens-an update.Front Pharmacol. 2013;4:101-101
44. Bosland MC.The role of steroid hormones in prostate carcinogenesis.J Natl Cancer Inst Monogr. 2000;(27):39-66
45. Schroder F,Crawford ED,Axcrona K,Payne H,Keane TE.Androgen deprivation therapy: past, present and future.BJU Int. 2012;109:1-12
46. Fjosne HE,Ostensen MA,Haarstad H,Sunde A.Androgen regulation of polyamine synthesis in seminal vesicle and in different lobes of the rat prostate.Prostate. 1990;17:1-11
47. Simanainen U,McNamara K,Davey RA,Zajac JD,Handelsman DJ.Severe subfertility in mice with androgen receptor inactivation in sex accessory organs but not in testis.Endocrinology. 2008;149:3330-8
48. Creed KE,Carati CJ,Keogh EJ.The physiology of penile erection.Oxford Rev Reprod Biol. 1991;13:73-95
49. Welsh M,MacLeod DJ,Walker M,Smith LB,Sharpe RM.Critical androgen-sensitive periods of rat penis and clitoris development.Int J Androl. 2010;33:e144-52
50. Husmann DA.Micropenis: an animal model and its human correlates.Adv Exp Med Biol. 2002;511:41-54
51. Schirar A,Bonnefond C,Meusnier C,Devinoy E.Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat.Endocrinology. 1997;138:3093-102
52. Traish AM.Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review.J Androl. 2009;30:363-9
53. Robaire B,Bayly SF.Testicular signaling: incoming and outgoing messages.Ann N Y Acad Sci. 1989;564:250-60
54. Mital P,Hinton BT,Dufour JM.The blood-testis and blood-epididymis barriers are more than just their tight junctions.Biol Reprod. 2011;84:851-8
55. Setchell BP.Blood-testis barrier, junctional and transport proteins and spermatogenesis.Adv Exp Med Biol. 2008;636:212-33
56. Cheng CY,Mruk DD.The blood-testis barrier and its implications for male contraception.Pharmacol Rev. 2012;64:16-64
57. Betancourt-Albrecht M,Cunningham GR.Hypogonadism and diabetes.Int J Impotence Res. 2003;15:S14-20
58. Goldenberg RL,Culhane JF,Iams JD,Romero R.Epidemiology and causes of preterm birth.Lancet. 2008;371:75-84
59. Minino AM,Murphy SL,Xu J,Kochanek KD.Deaths: final data for 2008.Natl Vital Stat Rep. 2011;59:1-126
60. Boudou T,Legant WR,Mu A,Borochin MA,Thavandiran N,Radisic M,Zandstra PW,Epstein JA,Margulies KB,Chen CS.A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues.Tissue Eng A. 2012;18:910-9
61. Kim J,Park J,Na K,Yang S,Baek J,Yoon E,Choi S,Lee S,Chun K,Park J,Park S.Quantitative evaluation of cardiomyocyte contractility in a 3D microenvironment.J Biomech. 2008;41:2396-401
62. De Lignieres B,Basdevant A,Thomas G,Thalabard JC,Mercier-Bodard C,Conard J,Guyene TT,Mairon N,Corvol P,Guy-Grand B, et al.Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.J Clin Endocrinol Metab. 1986;62:536-41
63. Schunkert H,Danser AH,Hense HW,Derkx FH,Kurzinger S,Riegger GA.Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.Circulation. 1997;95:39-45
64. Hilliard LM,Sampson AK,Brown RD,Denton KM.The “his and hers” of the renin-angiotensin system.Curr Hypertens Rep. 2013;15:71-9
65. Georgiadou P,Sbarouni E.Effect of hormone replacement therapy on inflammatory biomarkers.Adv Clin Chem. 2009;47:59-93
66. Skogastierna C, Hotzen M, Rane A, Ekstrom L. A supraphysiological dose of testosterone induces nitric oxide production and oxidative stress. Eur J Prev Cardiol. Epub ahead of print 9 March 2013.
67. Messerli FH,Garavaglia GE,Schmieder RE,Sundgaard-Riise K,Nunez BD,Amodeo C.Disparate cardiovascular findings in men and women with essential hypertension.Ann Intern Med. 1987;107:158-61
68. Mugge A,Riedel M,Barton M,Kuhn M,Lichtlen PR.Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro.Cardiovasc Res. 1993;27:1939-42
69. Woodard GA,Brooks MM,Barinas-Mitchell E,Mackey RH,Matthews KA,Sutton-Tyrrell K.Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women.Menopause. 2011;18:376-84
70. Surawicz B,Parikh SR.Differences between ventricular repolarization in men and women: description, mechanism and implications.Ann Noninvas Electrocardiol. 2003;8:333-40
71. Reckelhoff JF,Maric C.Sex and gender differences in cardiovascular-renal physiology and pathophysiology.Steroids. 2010;75:745-6
72. McSweeney JC,Cody M,O'Sullivan P,Elberson K,Moser DK,Garvin BJ.Women's early warning symptoms of acute myocardial infarction.Circulation. 2003;108:2619-23
73. Maas AH,Appelman YE.Gender differences in coronary heart disease.Neth Heart J. 2010;18:598-603
74. Shaw LJ,Bugiardini R,Merz CN.Women and ischemic heart disease: evolving knowledge.J Am Coll Cardiol. 2009;54:1561-75
75. Mosca L,Banka CL,Benjamin EJ,Berra K,Bushnell C,Dolor RJ,Ganiats TG,Gomes AS,Gornik HL,Gracia C,Gulati M,Haan CK,Judelson DR,Keenan N,Kelepouris E,Michos ED,Newby LK,Oparil S,Ouyang P,Oz MC,Petitti D,Pinn VW,Redberg RF,Scott R,Sherif K,Smith SC,Jr, Sopko G,Steinhorn RH,Stone NJ,Taubert KA,Todd BA,Urbina E,Wenger NK.Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.Circulation. 2007;115:1481-501
76. Manson JE,Hsia J,Johnson KC,Rossouw JE,Assaf AR,Lasser NL,Trevisan M,Black HR,Heckbert SR,Detrano R,Strickland OL,Wong ND,Crouse JR,Stein E,Cushman M.Estrogen plus progestin and the risk of coronary heart disease.N Engl J Med. 2003;349:523-34
77. Rossouw JE,Prentice RL,Manson JE,Wu L,Barad D,Barnabei VM,Ko M,LaCroix AZ,Margolis KL,Stefanick ML.Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.JAMA. 2007;297:1465-77
78. Corona G,Rastrelli G,Monami M,Guay A,Buvat J,Sforza A,Forti G,Mannucci E,Maggi M.Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.Eur J Endocrinol. 2011;165:687-701
79. Traish AM,Saad F,Feeley RJ,Guay A.The dark side of testosterone deficiency: III. Cardiovascular disease.J Androl. 2009;30:477-94
80. Keymel S,Kalka C,Rassaf T,Yeghiazarians Y,Kelm M,Heiss C.Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening.Basic Res Cardiol. 2008;103:582-6
81. Webb CM,McNeill JG,Hayward CS,de Zeigler D,Collins P.Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.Circulation. 1999;100:1690-6
82. Vigen R,O'Donnell CI,Baron AE,Grunwald GK,Maddox TM,Bradley SM,Barqawi A,Woning G,Wierman ME,Plomondon ME,Rumsfeld JS,Ho PM.Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.JAMA. 2013;310:1829-36
83. Shores MM,Smith NL,Forsberg CW,Anawalt BD,Matsumoto AM.Testosterone treatment and mortality in men with low testosterone levels.J Clin Endocrinol Metab. 2012;97:2050-8
84. Clodfelter KH,Holloway MG,Hodor P,Park SH,Ray WJ,Waxman DJ.Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis.Mol Endocrinol. 2006;20:1333-51
85. Waxman DJ,Holloway MG.Sex differences in the expression of hepatic drug metabolizing enzymes.Mol Pharmacol. 2009;76:215-28
86. Papageorgiou I,Grepper S,Unadkat JD.Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines.Drug Metab Dispos. 2013;41:281-90
87. Eden S.Age- and sex-related differences in episodic growth hormone secretion in the rat.Endocrinology. 1979;105:555-60
88. Meinhardt UJ,Ho KKY.Modulation of growth hormone action by sex steroids.Clin Endocrinol. 2006;65:413-22
89. Becker U,Deis A,Sorensen TI,Gronbaek M,Borch-Johnsen K,Muller CF,Schnohr P,Jensen G.Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study.Hepatology. 1996;23:1025-9
90. Schenker S,Speeg KV.The risk of alcohol intake in men and women.N Engl J Med. 1990;322:127-9
91. Thurman RG.Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin.Can J Gastroenterol. 2000;14:129D-35D
92. Naugler WE,Sakurai T,Kim S,Maeda S,Kim K,Elsharkawy AM,Karin M.Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.Science. 2007;317:121-4
93. Li Z,Tuteja G,Schug J,Kaestner KH.Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.Cell. 2012;148:72-83
94. Austin KL,Mather LE,Philpot CR,McDonald PJ.Intersubject and dose-related variability after intravenous administration of erythromycin.Br J Clin Pharmacol. 1980;10:273-9
95. Kashuba AD,Nafziger AN.Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.Clin Pharmacokinet. 1998;34:203-18
96. Denisov IG,Grinkova YV,McLean MA,Sligar SG.The one-electron autoxidation of human cytochrome P450 3A4.J Biol Chem. 2007;282:26865-73
97. Schuetz EG,Furuya KN,Schuetz JD.Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.J Pharmacol Exp Ther. 1995;275:1011-8
98. Anderson GD.Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.Clin Pharmacokinet. 2005;44:989-1008
99. Rizvi K,Hampson JP,Harvey JN.Do lipid-lowering drugs cause erectile dysfunction? A systematic review.Fam Pract. 2002;19:95-8
100. Kazmin A,Garcia-Bournissen F,Koren G.Risks of statin use during pregnancy: a systematic review.J Obstet Gynaecol Can. 2007;29:906-8
101. Lecarpentier E,Morel O,Fournier T,Elefant E,Chavatte-Palmer P,Tsatsaris V.Statins and pregnancy: between supposed risks and theoretical benefits.Drugs. 2012;72:773-88
102. Veiby G,Daltveit AK,Schjolberg S,Stoltenberg C,Oyen AS,Vollset SE,Engelsen BA,Gilhus NE.Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.Epilepsia. 2013;54:1462-72
103. Coluzzi F, Valensise H, Sacco M, Allegri M. Chronic pain management in pregnancy and lactation. Minerva Anestesiol. Epub ahead of print 17 July 2013.
104. Ross LE,Grigoriadis S,Mamisashvili L,Vonderporten EH,Roerecke M,Rehm J,Dennis CL,Koren G,Steiner M,Mousmanis P,Cheung A.Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.JAMA Psychiatry. 2013;70:436-43
105. Mosenifar Z.Population issues in clinical trials.Proc Am Thorac Soc. 2007;4:185-7
106. Wallace WH,Anderson RA,Irvine DS.Fertility preservation for young patients with cancer: who is at risk and what can be offered?.Lancet Oncol. 2005;6:209-18
107. Matsuura K, Naruse K. Use of silicone elastomer-based microfluidic devices and systems in reproductive technologies. In: Boczkowska A (ed.) Advanced elastomers: technology, properties and applications. Rijeka: InTech, 2012, pp.243–62.
108. Li W-X,Liang G-T,Yan W,Zhang Q,Wang W,Zhou X-M,Liu D-Y.Artificial uterus on a microfluidic chip.Chin J Anal Chem. 2013;41:467-72
109. Grosberg A,Nesmith AP,Goss JA,Brigham MD,McCain ML,Parker KK.Muscle on a chip: in vitro contractility assays for smooth and striated muscle.J Pharmacol Toxicol Meth. 2012;65:126-35
110. Khaderi SN,Craus CB,Hussong J,Schorr N,Belardi J,Westerweel J,Prucker O,Ruhe J,den Toonder JM,Onck PR.Magnetically-actuated artificial cilia for microfluidic propulsion.Lab Chip. 2011;11:2002-10
111. Ponec M.Skin constructs for replacement of skin tissues for in vitro testing.Adv Drug Deliv Rev. 2002;54:S19-30
112. Domansky K,Inman W,Serdy J,Dash A,Lim MH,Griffith LG.Perfused multiwell plate for 3D liver tissue engineering.Lab Chip. 2010;10:51-8
113. Kim HJ,Huh D,Hamilton G,Ingber DE.Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.Lab Chip. 2012;12:2165-74
114. DiMasi JA,Feldman L,Seckler A,Wilson A.Trends in risks associated with new drug development: success rates for investigational drugs.Clin Pharmacol Ther. 2010;87:272-7
115. DiMasi JA,Hansen RW,Grabowski HG.The price of innovation: new estimates of drug development costs.J Health Econ. 2003;22:151-85
116. United States Government Accounting Office. Drug Safety: Most drugs withdrawn in recent years had greater health risks for women. GAO-01-286R Drugs Withdrawn From Market. January 19, 2001. http://www.gao.gov/new.items/d01286r.pdf.